Merriman Curhan Ford

WASHINGTON, Oct. 10 /PRNewswire/ -- NFL PLAYERS, the licensing and marketing subsidiary of the NFL Players Association, will follow up last year's successful branding campaign with its 2008 installment: "Football doesn't define me." With the unveiling of NFLPLAYERS.COM/REAL, a new interactive micro site, fans are given an exclusive, under-the-helmet look at 18 of the NFL's top players. "The new micro site builds on our vision of implementing cutting-edge technology to expand upon the successful NFL PLAYERS brand," said Andy Feffer, NFL PLAYERS COO and Executive Vice President. "The interactive experience instantly engages fans as it reveals the unique stories and characteristics of our players." The "REAL" micro site Though last year's micro site won numerous honors, the latest installment goes above and beyond the high standard set before it. Produced by NFL PLAYERS and Forty Forty, a Berkeley, Calif., based branding agency, the new micro site features downloadable desktop ...

TYNGSBORO, Mass.--(BUSINESS WIRE)-- Beacon Power Corporation (NASDAQ: BCON), today announced that it has received a commitment for $7.9 million of new investment in the Company. The capital will be used to fund ongoing operations, including the completion of manufacturing of flywheel systems for commercial deployment of five Megawatts of frequency regulation service by the end of 2008. The transaction is expected to close on October 15, 2008. The Company will sell 8.7 million units for $0.91 per unit. Each unit consists of one share of the Company's common stock, par value $0.01 per share, and one warrant to purchase one share of the Company's common stock at an exercise price of $1.20 per share. The net proceeds to the Company are expected to be approximately $7.2 million after deducting placement agency fees and estimated expenses. The warrants will be immediately separable from the units, and will be exercisable beginning six months and one ...

Fox-Pitt Kelton downgrades Merriman Curhan Ford (Nasdaq: MERR) from ...

Merriman Curhan Ford initiates coverage on Polypore (NYSE ...

ATLANTA, GA -- (MARKET WIRE) -- 10/07/08 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it has consented to the Involuntary Chapter 7 Petition filed against the Company on September 15, 2008 in the U.S. Bankruptcy Court for the Northern District of Georgia, and has filed to convert the case to a case under Chapter 11 of the United States Bankruptcy Code. The filing became necessary as a result of the Company's substantial debt burden, which created a significant impediment to its ability to effectively develop its primary asset, AGI-1067. During the bankruptcy proceedings, AtheroGenics expects to sell the Company and/or its key assets. Proceeds from any transactions will be distributed to the Company's stakeholders, including its creditors. Prior to the sale process, AtheroGenics cannot forecast the amount ...